Spear Bio
Ultra-sensitive protein biomarker immunoassay kits and testing services for neuroscience researchers and clinicians
Highlights
- Hiring1 open role
- New on EvolcAdded 2026-10-28
- Remote-friendly1 of 1 open role remote or hybrid
About Spear Bio
Spear Bio develops SPEAR UltraDetect biomarker assays, a homogeneous, wash-free immunoassay format using two-factor proximity binding with qPCR readout. The company also offers SPEAR Evaluation Services and SPEAR Research Accelerator, biomarker testing services that let researchers trial the platform before adopting it.
Customers are academic and clinical researchers working on biomarkers, particularly neurodegenerative diseases. Revenue comes from assay kits and sample testing services. Its sales organisation is recruiting business development managers for immunoassays and biomarkers across US regions, London and Germany.
Spear Bio is headquartered in Woburn, Massachusetts, and was founded by co-founders who developed the SPEAR technology at Harvard's Wyss Institute for Biologically Inspired Engineering. Its quality management system is certified to ISO 13485:2016. Open roles span R&D (assay development, instrumentation and automation engineering) and commercial positions.
Product: SPEAR UltraDetect protein biomarker assay kits and SPEAR evaluation and research sample-testing services.
Jobs at Spear Bio (1)
Spear Bio is hiring for one role in sales, based in London. One is remote.
Business Development Manager, Immunoassays & Biomarkers (EMEA)
New on EvolcRemote-friendly
Companies hiring like Spear Bio
Leadership
- Peng Yin · Director & Co-FounderSource: company website
- Feng Xuan · Chief Executive Officer & Co-founderSource: company website
- Zidong Wang · Chief Operating OfficerSource: company website
- Gerry Andros · SVP, CommercialSource: company website
- Oliver Tassinari · VP, Business Development & SalesSource: company website
- Jen Katzburg · VP, Talent & CultureSource: company website
More biotech & pharma companies
Turbine
AI-driven virtual biology platform for biopharma research and drug discovery teamsVaxcyte
Clinical-stage vaccine developer of pneumococcal conjugate vaccines for infants and older adults, with Strep A and Shigella programsRemote-friendlyWatchmaker Genomics
Enzymes and reagents for NGS library prep and molecular diagnostics, sold to life science researchers and diagnostics developersRemote-friendlyAcadia Pharmaceuticals
Develops medicines for people with neurological and rare diseasesRemote-friendlyAllucent
Contract research services for small and mid-size biotech and biopharma sponsors in clinical development and regulatory strategyRemote-friendlyAltos Labs
Biotech developing cell rejuvenation medicines to reverse disease, with sites in San Francisco Bay Area, San Diego and Cambridge, UKSalary transparent
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
- Lucky OrangeHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
CRM & customer data
- HubSpotHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.